SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-029299
Filing Date
2014-05-12
Accepted
2014-05-12 08:31:31
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v375614_10q.htm 10-Q 356595
2 EXHIBIT 31.1 v375614_ex31-1.htm EX-31.1 11027
3 EXHIBIT 31.2 v375614_ex31-2.htm EX-31.2 11118
4 EXHIBIT 32.1 v375614_ex32-1.htm EX-32.1 6299
  Complete submission text file 0001144204-14-029299.txt   4151396

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20140331.xml EX-101.INS 609284
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20140331.xsd EX-101.SCH 43315
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20140331_cal.xml EX-101.CAL 40874
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20140331_def.xml EX-101.DEF 217925
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20140331_lab.xml EX-101.LAB 277995
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20140331_pre.xml EX-101.PRE 257782
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 14831407
SIC: 2834 Pharmaceutical Preparations